Description
+ Include: 17 videos + 1 pdf, size: 4.89 GB
+ Target Audience: cardiologist, oncologist, internists, sonographers
+ Sample video: contact me for sample video
+ Topics:
brochure_cmp21_compressed2.pdf
SESSION I AMYLOIDOSIS – Clinical Presentation of Amyloidosis Who to Suspect.mp4
SESSION I AMYLOIDOSIS – Diagnostic Testing in Cardiac Amyloidosis.mp4
SESSION I AMYLOIDOSIS – Panel Discussion Q&A.mp4
SESSION I AMYLOIDOSIS – Treatment of ATTR Amyloidosis New Drugs on the Horizon.mp4
SESSION I AMYLOIDOSIS – Updates in AL Amyloidosis Management.mp4
SESSION II CARDIO-ONCOLOGY – Best Practices in Managing Cardiac Toxicity in the Breast Cancer Patient The Cardiologist’s Perspective.mp4
SESSION II CARDIO-ONCOLOGY – Best Practices in Managing Cardiac Toxicity in the Breast Cancer Patient The Oncologist’s Perspective.mp4
SESSION II CARDIO-ONCOLOGY – Cardiotoxicity of Newer Oncology Therapies A Brave New World.mp4
SESSION II CARDIO-ONCOLOGY – Multimodality Imaging in Cardio-Oncology.mp4
SESSION II CARDIO-ONCOLOGY – Panel Discussion Q&A.mp4
SESSION II CARDIO-ONCOLOGY – Strategies to Minimize Radiation-Induced Heart Disease.mp4
SESSION III CARDIOMYOPATHIES – Cardiac Sarcoidosis The Cardiologist’s Perspective.mp4
SESSION III CARDIOMYOPATHIES – Cardiac Sarcoidosis The Rheumatologist’s Perspective.mp4
SESSION III CARDIOMYOPATHIES – Hypertrophic Cardiomyopathy MRI to Mavacamten.mp4
SESSION III CARDIOMYOPATHIES – Panel Discussion Q&A.mp4
SESSION III CARDIOMYOPATHIES – Peripartum Cardiomyopathy.mp4
SESSION III CARDIOMYOPATHIES – The Role of Genetic Testing in Cardiomyopathies.mp4
Reviews
There are no reviews yet.